IP Library Granted Patent US 10,299,994
Granted Patent B2
US 10,299,994 · App. 15/283,884 · Granted May 28, 2019

Cosmetic compositions and uses thereof

Inventors: Tiffany Florence (Dallas, TX); Michelle Hines (Hickory Creek, TX); David Gan (Southlake, TX)
Assignee: Mary Kay Inc.
A61K8/04A61K8/365A61K8/4953A61K8/602A61K8/922A61K8/97A61K8/9706A61Q19/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,299,994
App. No.
15/283,884
Granted
May 28, 2019
Kind
B2
Abstract

Disclosed is a method for reducing the appearance of cellulite or improving the texture of skin in a target region of skin that has cellulite or rough skin texture, the method comprising topically applying a composition to the target region that includes an effective amount of a mixture of caffeine, escin, and an aqueous-alcoholic extract from Ascophyllum nodosum , wherein topical application of the composition reduces the appearance of cellulite or improves the texture of the skin.

Claims (18)

1. A method for reducing the appearance of cellulite or improving the texture of skin in a target region of skin that has cellulite or rough skin texture, the method comprising topically applying a composition to the target region that includes an effective amount of a mixture of caffeine, escin, and an aqueous-alcoholic extract from Ascophyllum nodosum , wherein topical application of the composition reduces the appearance of cellulite or improves the texture of the skin.

2. The method of claim 1 , wherein the composition further comprises effective amounts of Rubus fruticosus extract, Argania spinosa kernel oil, Coleus barbatus extract, and glycolic acid.

3. The method of claim 2 , wherein the effective amounts are 0.001 to 10% by weight of the mixture of caffeine, escin, and the aqueous-alcoholic extract from Ascophyllum nodosum, 0.001 to 10% by weight of the aqueous-alcoholic extract from Rubus fruticosus leaf, 0.001 to 10% by weight of Argania spinosa kernel oil, 0.001 to 10% by weight of the Coleus barbatus root extract, and 0.001 to 10% by weight of glycolic acid.

4. The method of claim 2 , wherein the composition increases skin firmness or elasticity in said target region.

5. The method of claim 2 , wherein the composition increases lipolysis in adipocytes.

6. The method of claim 2 , wherein the composition decreases maturation of fat cells.

7. The method of claim 2 , wherein the target region comprises a dimple, and wherein the composition reduces the appearance of the dimple.

8. The method of claim 7 , wherein the composition reduces the difference between the peak and valley of the dimple.

9. The method of claim 2 , wherein the composition decreases the size of adipocytes in the target region.

10. The method of claim 9 , wherein the composition decreases the size of adipocytes in the target region having a diameter of equal to or greater than 40 μm or have a diameter between 40-160 μm.

11. The method of claim 10 , wherein between 5 and 20% of the adipocytes in the target region having a diameter of equal to or greater than 40 μm or have a diameter between 40-160 μm are decreased in size.

12. The method of claim 2 , wherein the composition increases the epidermal thickness of skin in the target region between 5 and 50%.

13. The method of claim 2 , wherein the composition increases triglyceride release from adipocytes in the target region.

14. The method of claim 1 , wherein the composition is formulated as a cream, lotion, or gel.

15. The method of claim 1 , wherein the composition is formulated as an emulsion.

16. The method of claim 1 , wherein the skin is leg skin, arm skin, torso skin, or skin in the pelvic region.

17. The method of claim 16 , wherein the composition is applied to the skin and remains on the skin for at least 5 minutes after topical application.

18. The method of claim 1 , wherein the mixture of caffeine, escin, and the aqueous-alcoholic extract is not encapsulated in nanoparticles.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2022
From: BELAJ INNOVATIONS, LLC
To: MARY KAY INC.
Reel/Frame 062144/0439 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2020
From: ALLUSTRA TECHNOLOGIES LLC
To: BELAJ INNOVATIONS LLC
Reel/Frame 054186/0468 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2020
From: MARY KAY INC.
To: ALLUSTRA TECHNOLOGIES LLC
Reel/Frame 054112/0400 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2016
From: FLORENCE, TIFFANY; HINES, MICHELLE; GAN, DAVID
To: MARY KAY INC.
Reel/Frame 039923/0685 →
Continuity (4)
Continuation 14204553 · Mar 11, 2014
Provisional Application 61877731 · Sep 13, 2013
Provisional Application 61788195 · Mar 15, 2013
Related Publication 20170020806A1 · Jan 26, 2017